Clinical Trials Sponsored by The First People's Hospital of Changzhou

Total 2965 results

The First People's Hospital of Changzhou

Not yet recruiting

SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Cytokine-Induced Killer Cells | Advanced Milignant Gliomas
The First People's Hospital of Changzhou

Active, not recruiting

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

Colorectal Neoplasms
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Ovarian Carcinoma
The First People's Hospital of Changzhou

Active, not recruiting

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer

Breast Cancer
The First People's Hospital of Changzhou

Active, not recruiting

CIK in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms
The First People's Hospital of Changzhou

Not yet recruiting

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Melanoma
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Cytokine-Induced Killer Cells | Milignant Gliomas
The First People's Hospital of Changzhou

Not yet recruiting

CIK in Treating Patients With Esophageal Cancer

Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou

Not yet recruiting

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Renal Neoplasma
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Cholangiocarcinoma

China
The First People's Hospital of Changzhou

Completed

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

Colorectal Cancer
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Cervical Cancer
The First People's Hospital of Changzhou

Active, not recruiting

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Gastric Cancer
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

Stomach Neoplasms
The First People's Hospital of Changzhou

Completed

Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

Colorectal Cancer
The First People's Hospital of Changzhou

Completed

TOF Versus SOX in Metastatic Gastric Cancer

Gastric Cancer
The First People's Hospital of Changzhou

Completed

Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

Rectum Cancer
The First People's Hospital of Changzhou

Completed

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Colorectal Cancer

China
The First People's Hospital of Changzhou

Unknown

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Colorectal Neoplasm

China
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR

Adenocarcinoma of Lung
jiangjingting

Unknown

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Lymphoma, B Cell

China
chenwu

Recruiting

Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

Gastric Cancer | Circulating Tumor DNA (ctDNA)

China
Wu Jun

Not yet recruiting

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

Adenocarcinoma | Gastric Cancer | GastroEsophageal Cancer

China
Wu Jun

Recruiting

Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study

Gastric Cancer

China
First People's Hospital of Hangzhou

Recruiting

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Chronic Hepatitis b | Tenofovir Alafenamide Fumarate

China
First People's Hospital of Hangzhou

Not yet recruiting

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

Biliary Tract Cancer | Gemcitabine | Immune Checkpoint Inhibitors

China
First People's Hospital of Hangzhou

Not yet recruiting

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation

Colon Disease
First People's Hospital of Hangzhou

Recruiting

A Single-arm, Phase Ⅱ Clinical Trial of Anlotinib Hydrochloride Combined With Irinotecan or Docetaxel for Second Line Treatment of Nonsensitive Relapsed Small-cell Lung Cancer

Relapsed Small Cell Lung Cancer | Anlotinib

China
First People's Hospital of Hangzhou

Recruiting

A Non-invasive Index of Microciculatory Resistance

Coronary Artery Disease | Coronary Microvascular Disease

China
First People's Hospital of Hangzhou

Completed

SpyGlass Versus ESWL for Large Common Bile Duct Stones

Choledocholithiasis | Common Bile Duct Calculi

China
First People's Hospital of Hangzhou

Completed

EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary Extension

Ampullary Adenomas

China
First People's Hospital of Hangzhou

Completed

Clinical Effect and Safety of PDT and RFA for Unresectable EHCC

Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Completed

Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma

Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Completed

Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma

Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Unknown

ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

Non-small Cell Lung Cancer Stage III | Adenocarcinoma of Lung | Non-Small-Cell Lung Cancer Metastatic | EGFR Wildtype

China
First People's Hospital of Hangzhou

Unknown

A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy

Lung Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer
First People's Hospital of Hangzhou

Completed

Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis

Cholangitis | Complication

China
First People's Hospital of Hangzhou

Unknown

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell

China
First People's Hospital of Hangzhou

Recruiting

Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma

Bile Duct Cancer | Extrahepatic Cholangiocarcinoma

China
First People's Hospital of Hangzhou

Not yet recruiting

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
First People's Hospital of Hangzhou

Completed

Distinct Alterations in Gut Microbiota Composition Among Women of Reproductive Age With Elevated Homocysteine Levels.

Recurrent Miscarriage

China
First People's Hospital of Hangzhou

Enrolling by invitation

Spyglass-guided Lithotripsy Versus ESWL for Pancreatic Duct Stones

Pancreatic Duct Stone

China
First People's Hospital of Hangzhou

Completed

EUS-guided Biliary Drainage vs. ERCP Assisted Transpapillary Drainage for Malignant Biliary Obstruction

Malignant Biliary Obstruction

China
First People's Hospital of Hangzhou

Completed

A Comparison Between Lumen-apposing Metal Stent and Double-pigtail Plastic Stents for Treatment of Walled-off Necrosis

Walled-off Necrosis

China
First People's Hospital of Hangzhou

Completed

EUS-RFA for Unresectable Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

China
First People's Hospital of Hangzhou

Completed

EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

Pancreatic Adenocarcinoma Non-resectable

China
First People's Hospital of Hangzhou

Unknown

Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.

Thyroid Nodule

China
First People's Hospital of Hangzhou

Completed

T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure

Non-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer Metastatic

China

Clinical Trials Sponsored by The First People's Hospital of Changzhou

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations